Interest in exosomes has grown of late, particularly since they have been seen to take part in functional interactions with antigen-presenting cells, and in the modulation of the immune response in ...

On a conceptual level, the benefits of “twenty-four seven” drug production are obvious. The ability to make more product, more quickly, and more efficiently will increase access to medicines and help ...

For certain APIs, including semi-synthetic antibiotics, continuous filtration and drying improves productivity and quality. Continuous processes for production of antibiotics, including downstream ...

Continuous manufacturing and a quality-by-design development approach are a natural fit. FDA, as well as other regulatory agencies around the world, have for many years been encouraging drug makers to ...

A photo of technicians working in front of a process train. Novartis's continuous manufacturing center in Basel, Switzerland, replicates an end-to-end manufacturing process developed at the ...

The biopharmaceutical industry has seen substantial growth in recent years, generating novel biotherapeutics and biosimilars at an unprecedented rate. One of the biggest challenges in the industry is ...

Evidence from several Shell operating units confirms that daily allocation based on continuous well flow estimates can be more accurate than the more traditional approach based on well testing. The ...

The manufacture of medicines must draw on expertise from a wide range of disciplines, from the initial investigation and design of a new drug or therapeutic to wide-scale production and distribution, ...